Source: https://www.pabulletin.com/secure/data/vol48/48-33/1264.html
Timestamp: 2018-09-21 00:43:11
Document Index: 3497572

Matched Legal Cases: ['§\u200210231', '§\u200210231', '§\u200210231', '§\u20021201', '§\u2002745', '§\u2002732', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021141', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u200267', '§\u20021211', '§\u200210231', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u200210231', '§\u200210231', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021211', '§\u20021161', '§\u20021211', '§\u20021211', '§\u20021211', '§\u200210231', '§\u20021211', '§\u20021211', '§\u20021211']

PA Bulletin, Doc. No. 18-1264>
[48 Pa.B. 5027]
The Department of Health (Department) is publishing temporary regulations in Chapter 1211 (relating to clinical registrants and academic clinical research centers—temporary regulations) to read as set forth in Annex A. The temporary regulations are published under the Medical Marijuana Act (act) (35 P.S. §§ 10231.101—10231.2110), as amended by the act of June 22, 2018 (P.L. 322, No. 43). Section 2004 of the act (35 P.S. § 10231.2004) specifically allows the Department to promulgate temporary regulations relating solely to sections 2000—2004 of the act (35 P.S. §§ 10231.2000—10231.2004), regarding academic clinical research centers and clinical registrants, that are not subject to sections 201—205 of the act of July 31, 1968 (P.L. 769, No. 240) (45 P.S. §§ 1201—1205), known as the Commonwealth Documents Law, the Regulatory Review Act (71 P.S. §§ 745.1—745.14) and sections 204(b) and 301(10) of the Commonwealth Attorneys Act (71 P.S. §§ 732-204(b) and 732-301(10)).
Chapter 1211 pertains to clinical registrants and academic clinical research centers in this Commonwealth who wish to participate in the Medical Marijuana Program. The temporary regulations for clinical registrants and academic clinical research centers will expire on March 18, 2020.
(Editor's Note: Title 28 of the Pennsylvania Code is amended by adding temporary regulations in §§ 1211.21—1211.37 to read as set forth in Annex A.)
Fiscal Note: 10-217. No fiscal impact; (8) recommends adoption.
1211.21. Definitions.
1211.22. Clinical registrants generally.
1211.23. Limitation on permits.
1211.24. Capital requirements.
1211.25. Certifying ACRCs.
1211.26. Revocation of a certification of an ACRC.
1211.27. Application for approval of a clinical registrant.
1211.28. Request for conversion of an existing permit.
1211.29. Practices and procedures of research programs, projects or studies.
1211.30. Approval or denial of an application for approval of a clinical registrant.
1211.31. Renewal of approval of a clinical registrant.
1211.32. Revocation of approval of a clinical registrant.
1211.33. Dispensing and tracking medical marijuana products.
1211.34. Prohibition.
1211.35. Reporting requirements.
1211.36. Sale or exchange.
1211.37. Appeals.
IRB—Institutional review board—A board, committee, RAC or group designated by a certified ACRC that reviews and approves the anticipated scope of an approved clinical registrant's research study involving human subjects under the criteria in 45 CFR 46.111 (relating to criteria for IRB approval of research) and 21 CFR 56.111 (relating to criteria for IRB approval of research).
RAC—Research approval committee—A board, committee or group created or designated by a certified ACRC to review and approve the scope and research protocols of a research program proposed by an approved clinical registrant.
Research contract—A written agreement between an approved clinical registrant and a certified ACRC that contains the responsibilities and duties of each party with respect to the research program or research study that the approved clinical registrant and the certified ACRC intend to conduct under this chapter and under which the certified ACRC will provide medical advice to the approved clinical registrant regarding, among other areas, patient health and safety, medical applications, and dispensing and management of controlled substances.
Research program—Research on the therapeutic or palliative efficacy of medical marijuana limited to the serious medical conditions defined by the act and this part.
Research project or study—Any other research on medical marijuana or its effectiveness in treating a medical or psychological condition.
Research protocol—A written procedure for conducting a research program or research study that includes all of the following information:
(ii) With respect to the research program or research study:
(A) Title of the research program or research study.
(D) Description of the research to be conducted, including the number and type of medical marijuana product, the dosage, the route and method of administration, and the duration of the research program or research study.
(E) The locations of the dispensaries that will be participating in the research program or research study.
§ 1211.22. Clinical registrants generally.
(1) Submit a request to the Department under § 1211.28 (relating to request for conversion of an existing permit) with the application for approval of a clinical registrant.
(d) An approved clinical registrant may not dispense or offer to dispense, as a clinical registrant, any medical marijuana products at the clinical registrant dispensary location until:
(2) The approved clinical registrant demonstrates to the satisfaction of the Department that it will be able to begin an approved research program or research study within 6 months following the date the Department determines the approved clinical registrant's dispensary to be operational.
(e) An approved clinical registrant may dispense medical marijuana products to a patient or caregiver who presents a valid identification card to an employee who is authorized to dispense medical marijuana products at a dispensary location operated by an approved clinical registrant under this chapter regardless of whether the patient is a participant in a research study.
§ 1211.23. Limitation on permits.
(b) A dispensary permit held by an approved clinical registrant for use under this chapter may be used to dispense medical marijuana products at no more than six separate locations as approved by the Department, each of which shall be dispensing medical marijuana for the purpose of conducting research.
§ 1211.24. Capital requirements.
An applicant shall provide all of the following information with its application under § 1211.27 (relating to application for approval of a clinical registrant):
(1) An affidavit, on a form prescribed by the Department, stating that the applicant has at least $15 million in capital, which must include evidence that the applicant meets the capital requirements of a medical marijuana organization under § 1141.30 (relating to capital requirements).
§ 1211.25. Certifying ACRCs.
(1) The legal name, address and telephone number of the accredited medical school and the name, telephone number and professional e-mail address of an individual at the accredited medical school who will be the primary contact for the Department during the Department's review of the application.
(2) The legal name, address and telephone number of the acute care hospital that is operated by or partnered with the accredited medical school and the name, telephone number and professional e-mail address of an individual at the accredited medical school who will be the primary contact for the Department during the Department's review of the application.
(d) The Department will publish a list containing the name and address of each certified ACRC on its publicly-accessible web site and in the Pennsylvania Bulletin.
§ 1211.26. Revocation of a certification of an ACRC.
§ 1211.27. Application for approval of a clinical registrant.
(1) The legal name, address and telephone number of the applicant and the name, telephone number and professional e-mail address of an individual who will be the primary contact for the Department during the Department's review of the application.
(2) The name of the certified ACRC under § 1211.25 (relating to certifying ACRCs).
(3) The applicant's State and Federal tax identification numbers.
(5) The name of an institution of higher education, if any, that will be participating in an approved research program or research study.
(6) An affidavit and release under § 1211.24 (relating to capital requirements).
(ii) A description of the research program or research study the applicant and the certified ACRC intend to conduct.
(iii) A statement that the applicant may not engage in the business of selling, dispensing or offering to dispense medical marijuana products at an applicant's dispensary as a clinical registrant until the clinical registrant dispensary is ready, willing and able to dispense medical marijuana products.
(8) Except as provided in § 1211.28 (relating to request for conversion of an existing permit), an application for a grower/processor permit under Chapters 1141 and 1151 (relating to general provisions—temporary regulations; and growers/processors—temporary regulations).
(9) Except as provided in § 1211.28, an application for a dispensary permit under Chapter 1141 and Chapter 1161 (relating to dispensaries—temporary regulations).
(d) The following documents provided to the Department under this chapter are confidential and not subject to disclosure under the Right-to-Know Law (65 P.S. §§ 67.101—67.3104):
(2) A description of a research program or research study.
(3) A certified ACRC's intellectual property.
(4) An approved clinical registrant's intellectual property.
§ 1211.28. Request for conversion of an existing permit.
(a) An applicant holding a grower/processor permit or a dispensary permit, or both, under sections 601—616 of the act (35 P.S. §§ 10231.601—10231.616), shall submit a request for conversion of an existing permit under this section on a form prescribed by the Department when submitting an application for approval of a clinical registrant under § 1211.27 (relating to application for approval of a clinical registrant).
(c) A grower/processor permit or dispensary permit, or both, surrendered under subsection (b) will increase the number of grower/processor permits or dispensary permits, as applicable, available to other persons applying for permits under sections 601—616 of the act, Chapter 1141 (relating to general provisions—temporary regulations) and Chapter 1151 or Chapter 1161 (relating to growers/processors—temporary regulations; and dispensaries—temporary regulations), as applicable.
§ 1211.29. Practices and procedures of research programs, projects or studies.
(a) Medical marijuana dispensed as part of a research program shall be dispensed only in a form permitted by the act or this part and only from a dispensary to a patient or to a caregiver.
(b) Marijuana dispensed under a research project or study may be dispensed, in any form deemed medically safe by an IRB, from a clinical registrant dispensary directly to an ACRC.
(c) A RAC or IRB shall adopt research procedures and shall review and approve each research program in accordance with the RAC or IRB established practices and procedures.
(d) An IRB shall review each proposed research project or study in accordance with the IRB's practices, procedures and protocols.
(e) A RAC or IRB shall, at a minimum, ensure that each research program, project or study addresses all of the following:
(1) Protecting the rights and welfare of patients involved in research programs conducted under this chapter.
(3) Determining that the risks to patients involved in research programs are reasonable in relation to the anticipated benefits (if any) to the patients, and the importance of the knowledge that may be expected to result from the research program.
(4) Guaranteeing that informed consent will be sought from each prospective patient or the patient's legally authorized representative and is properly documented.
§ 1211.30. Approval or denial of an application for approval of a clinical registrant.
(a) An applicant shall be an approved clinical registrant upon the Department's approval of an application under § 1211.27 (relating to application for approval of a clinical registrant).
(b) The Department may deny the application for approval of a clinical registrant if the payments disclosed in the affidavit submitted under § 1211.27(b)(4) violate the prohibition in § 1211.34 (relating to prohibition).
(c) Before the Department denies an application for approval of a clinical registrant under subsection (b), the Department will provide the applicant with written notice specifying the violation. The applicant may submit to the Department, within 10 days following receipt of the Department's written notice, a supplemental affidavit indicating that the certified ACRC or its affiliate has refunded to the applicant or a principal or financial backer of the applicant that portion of payments in violation of § 1211.34. Upon receipt of the supplemental affidavit, the Department may approve the application for approval of a clinical registrant. If the applicant fails to provide a supplemental affidavit within 10 days of the Department's written notice, the Department will deny the application for approval of a clinical registrant.
(d) An approved clinical registrant shall have the same rights and obligations as a medical marijuana organization that holds a grower/processor permit or a dispensary permit under sections 601—616 of the act (35 P.S. §§ 10231.601—10231.616) and Chapters 1141, 1151 and 1161 (relating to general provisions—temporary regulations; growers/processors—temporary regulations; and dispensaries—temporary regulations), as applicable, subject to any modifications or limitations in sections 2001—2003 of the act (35 P.S. §§ 10231.2001—10231.2003) and this chapter.
(e) A grower/processor permit and a dispensary permit issued to an approved clinical registrant will expire upon the nonrenewal, revocation or suspension by the Department of the approved clinical registrant's approval.
§ 1211.31. Renewal of approval of a clinical registrant.
(a) The term of an approval of a clinical registrant will coincide with the term of the clinical registrant's grower/processor permit and dispensary permit.
(2) A list of the approved research programs or research studies that are continuing or, if any of them are concluded, the dates they were concluded.
(3) A report of the current status of active research programs or research studies being conducted under the research contract, including preliminary findings, if applicable, and any expectations and projections the approved clinical registrant and the certified ACRC have for future research programs or research studies over the course of the 2 years following the date of submission of the report.
(4) A description of proposed research programs or research studies covered by the research contract that the approved clinical registrant intends to conduct within the next year following submission of the renewal application including evidence of IRB approval for each research program or research study.
(c) The Department will not renew an approval for a clinical registrant under this section if the Department determines that none of the dispensary locations under the dispensary permit held by the approved clinical registrant are participating in an approved research program or research study and the approved clinical registrant does not intend to begin any additional approved research programs or research studies within the first 6 months following the approval of its application for renewal.
§ 1211.32. Revocation of approval of a clinical registrant.
(2) Subject to subsection (b), the Department revokes the certification of the ACRC listed in the clinical registrant's application under § 1211.27 (relating to application for approval of a clinical registrant).
(b) If the Department intends to revoke the certification of the ACRC under subsection (a)(2), the Department will provide written notice of its intention to the approved clinical registrant. Upon receipt of a notice under this subsection, the approved clinical registrant shall have 90 days from the date of the notice to contract with another certified ACRC that is not already a party to a research contract with another approved clinical registrant and to provide the Department with all relevant information relating to the certified ACRC. If the approved clinical registrant does not comply with this subsection within 90 days from the date of the notice, the Department may revoke the clinical registrant's approval.
§ 1211.33. Dispensing and tracking medical marijuana products.
In addition to the information to be entered in the electronic tracking system under § 1161.39 (relating to electronic tracking system) with respect to medical marijuana products dispensed to all patients and caregivers, the dispensary of an approved clinical registrant shall enter information into the electronic tracking system as required by the Department that identifies patients that are enrolled in an approved research program or research study.
§ 1211.34. Prohibition.
§ 1211.35. Reporting requirements.
(a) Except as provided in subsection (b), an approved clinical registrant shall provide a written report of the findings of its research program or research study to the Department within 365 days of the completion of an approved research program or research study.
(b) In the event the approved clinical registrant or its certified ACRC intends to submit a manuscript of the results of an approved research program or research study to a peer-reviewed medical journal for publication, the written report required under subsection (a) shall be provided to the Department within 30 days following publication.
§ 1211.36. Sale or exchange.
(a) The grower/processor of an approved clinical registrant may sell or exchange the following items to another grower/processor:
(b) The grower/processor of an approved clinical registrant may only sell its medical marijuana products to either its own approved dispensaries or any other approved dispensaries of an approved clinical registrant.
(c) Notwithstanding subsection (b), an approved clinical registrant may petition the Department, on a form prescribed by the Department, to sell its medical marijuana products to a dispensary holding a permit under sections 601—616 of the act (35 P.S. §§ 10231.601—10231.616).
(d) A petition filed under subsection (c) must include either the report or manuscript required under § 1211.35 (relating to reporting requirements). If a clinical registrant fails to provide the report or manuscript required under § 1211.35, the petition will be denied.
§ 1211.37. Appeals.
[Pa.B. Doc. No. 18-1264. Filed for public inspection August 17, 2018, 9:00 a.m.]